Seitz M, Franke M, Kirchner H
Medizinische Poliklinik, University of Heidelberg, West Germany.
Ann Rheum Dis. 1988 Aug;47(8):642-4. doi: 10.1136/ard.47.8.642.
Of six patients with rheumatoid arthritis (RA) treated with human recombinant interferon gamma for two to eight months, three developed antinuclear antibodies (ANAs). This was accompanied by a simultaneous clinical exacerbation of the disease activity. In this study both anti-inflammatory and immunostimulatory effects of human recombinant interferon gamma in patients with RA were observed.
在接受重组人γ干扰素治疗两至八个月的六名类风湿性关节炎(RA)患者中,有三名出现了抗核抗体(ANA)。同时,疾病活动出现了临床加重。在本研究中,观察到了重组人γ干扰素对RA患者的抗炎和免疫刺激作用。